Griffipavixanthone TN4166
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Griffipavixanthone inhibits the growth of human Non-small-cell lung cancer H520 cells in dose- and time-dependent manners, it induces cell apoptosis through mitochondrial apoptotic pathway accompanying with ROS production. It can inhibit tumor metastasis
CAS nr:
219649-95-3
Purity:
98%
Molecular Weight:
652,6
SMILES:
CC1=C[C@H]2[C@H]([C@@H](c3c2c2c(oc4cc(O)cc(O)c4c2=O)c(O)c3O)c2cc(O)c(O)c3oc4cc(O)cc(O)c4c(=O)c23)C(C)(C)C1
Formula:
C36H28O12
Pathway:
MAPK,Immunology/Inflammation,Proteases/Proteasome,Apoptosis,MAPK,MAPK
Target:
Raf,ROS,Caspase,Caspase,MEK,ERK
